(Q37115730)

18 August 2017

Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates (English)

1 reference

18 August 2017

1 reference

1 reference

1 reference

1 reference

2

Saik Urien

0 references

Jean-Marc Tréluyer

14

object named as

Jean-Marc Tréluyer

0 references

François Dabis

13

object named as

François Dabis

1 reference

18 August 2017

10

Eric Nerrienet

1 reference

18 August 2017

Déborah Hirt

1

1 reference

18 August 2017

Saik Urien

2

1 reference

18 August 2017

Elisabeth Rey

3

1 reference

18 August 2017

Elise Arrivé

4

1 reference

18 August 2017

Didier K Ekouévi

5

1 reference

18 August 2017

Patrick Coffié

6

1 reference

18 August 2017

Sim Kruy Leang

7

1 reference

18 August 2017

Sarita Lalsab

8

1 reference

18 August 2017

Divine Avit

9

1 reference

18 August 2017

James McIntyre

11

1 reference

18 August 2017

Stéphane Blanche

12

1 reference

18 August 2017

Jean-Marc Tréluyer

14

1 reference

18 August 2017

language of work or name

English

0 references

publication date

22 December 2008

1 reference

Antimicrobial Agents and Chemotherapy

18 August 2017

1 reference

18 August 2017

53

1 reference

18 August 2017

3

1 reference

18 August 2017

1067-1073

1 reference

Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Ways to fit a PK model with some data below the quantification limit

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Antiretroviral pharmacology in pregnant women and their newborns.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Pharmacokinetic changes during pregnancy and their clinical relevance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Transit time in the small intestine in pregnancy

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Quantification of seven nucleoside/nucleotide reverse transcriptase inhibitors in human plasma by high-performance liquid chromatography with tandem mass-spectrometry

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650537

Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers

3 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19104016

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19104016

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Drug disposition and pharmacokinetics in the maternal-placental-fetal unit

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19104016

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00860-08

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19104016

1 reference